My name is Dr. Tim Gabor, I'm a Biotechnology Professor. I chat with experts in biotech in hopes of inspiring biotech students. Are you an expert that wants to motivate young scientists? Shoot me an email at invivothepodcast@gmail.com
LSD, Schizophrenia & The Madness Pill: Psychiatry’s Wildest Experiment | Dr. Justin Garson | Ep. 49
Philosopher and historian of science Dr. Justin Garson joins me to unpack The Madness Pill: One Doctor’s Quest to Understand Schizophrenia, the mid-century hunt for a pill that could temporarily induce schizophrenia so scientists could reverse-engineer a cure.
Garson opens with his father’s journey: diagnosed in 1973, treated for a time with talk therapy and no meds, then caught in the post-1980s biomedical turn of hospitals, antipsychotics, and side effects. The episode then centers Solomon Snyder, opiate receptor, dopamine receptor, grind-and-bind assays, and the arc from an LSD ego-death to amphetamine psychosis to the dopamine hypothesis that helped flip psychiatry toward chemical-imbalance models. Also: Hearing Voices Network, pathology vs purpose, and Garson’s Substack Reclaim Your Inner Life.
Dr. Justin Garson
Website: www.justingarson.com
X: x.com/justin_garson
Substack: www.reclaimyourinnerlife.com
Amazon (The Madness Pill): www.amazon.com/Madness-Pill-Doctors-Understand-Schizophrenia
In Vivo on X - https://x.com/InVivoPodOnX
In Vivo on Youtube - https://www.youtube.com/@InVivoPodcast
In Vivo on Apple Podcast - https://podcasts.apple.com/us/podcast/in-vivo/id1775578563
In Vivo on Amazon Podcasts - https://music.amazon.ca/podcasts/1ac4dbec-df46-4d1f-b0a1-742e9656ef44/in-vivo
The opinions in this episode are those of the speakers. They do not represent the official views of any college, university, company, or other institution I may work for.
29 Sept 2026
Autonomous Labs and the Coming Biotech Singularity | In Vivo w/ Dr. Jason Kelly | Ep. 48
Dr. Jason Kelly, co-founder and CEO of Ginkgo Bioworks, joins me to unpack autonomous labs, what they are, why biology’s bench tooling barely moved in 20 years, and why the right analogy isn’t a subway or a car, but a Waymo. Is the biology singularity around the corner?
Kelly traces his path from Jurassic Park–era genetic engineering dreams and failing to clone one gene as a freshman, through Drew Endy’s “DNA is code” vision at MIT, to bootstrapping Ginkgo for four years before becoming Y Combinator’s first biotech. Along the way: cells as atom-movers vs computers as bit-movers, why we’re still the “first batter” mastering biology, GPT-5 designing real wet-lab experiments on Ginkgo’s platform, and why US–China competition makes lab automation a national-security issue, including his work on the National Security Commission on Emerging Biotechnology and Genesis Mission / NSF autonomous-lab builds.
Dr Kelly: https://x.com/jrkelly
LinkedIn: https://www.linkedin.com/in/jrkelly2
Ginkgo: https://www.ginkgo.bio
In Vivo on X - https://x.com/InVivoPodOnX
In Vivo on Youtube - https://www.youtube.com/@InVivoPodcast
In Vivo on Apple Podcast - https://podcasts.apple.com/us/podcast/in-vivo/id1775578563
In Vivo on Amazon Podcasts - https://music.amazon.ca/podcasts/1ac4dbec-df46-4d1f-b0a1-742e9656ef44/in-vivo
The opinions in this episode are those of the speakers. They do not represent the official views of any college, university, company, or other institution I may work for.
15 Sept 2026
Editing Embryos: The Biotech Frontier That Changes Everything | Cathy Tie and Prof. Jiang | Ep. 47
Cathy Tie (founder, Origin Genomics) and Prof. Jiang Xueqin (Predictive History) join me for a wide-open conversation on germline gene editing, the science, the ethics, and the geopolitics.
Cathy walks through why heritable gene correction at the embryo stage may solve delivery problems that plague adult gene therapies, what Origin Genomics is doing under US IRB oversight, and how newer tools like base and prime editors change the safety conversation.
Prof. Jiang zooms out: US 0-to-1 vs China 1-to-100, techno-utopianism, aging demographics, and why, from a game-theory lens, biotech may reshape power more than nuclear weapons or AI.
Controversial, fast-moving science. This episode is for education and discussion, not medical or legal advice.
Cathy Tie / Origin Genomics:
https://x.com/CathyTie
https://x.com/OriginGenomics
https://www.linkedin.com/in/cathytie
https://www.origingenomics.com
Prof. Jiang Xueqin (Predictive History)
https://www.youtube.com/@PredictiveHistory
https://predictivehistory.substack.com
In Vivo on X - https://x.com/InVivoPodOnX
In Vivo on Youtube: https://www.youtube.com/@InVivoPodcast
In Vivo on Apple Podcast - https://podcasts.apple.com/us/podcast/in-vivo/id1775578563
In Vivo on Amazon Podcasts - https://music.amazon.ca/podcasts/1ac4dbec-df46-4d1f-b0a1-742e9656ef44/in-vivo
Who has been a guest on In Vivo
Names identified in recent episode analyses. Showing up to five guests.
Dr Oded Rechavi
Dr Josef Witt-Doerring
Dr Emma Hapke
Dr Shawn Baker
Dr Nicholas Fabiano
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
YouTube views
322,655
Score snapshot 15 Sept 2025
Apple Podcasts (US)
5.0 / 5
2 ratings
Spotify
5.0 / 5
3 ratings
Podcast Authority Score: 55 / 100
A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.
Quality
63
Social presence
0
YouTube
86
Engagement
32
Contact In Vivo
Guest appearances
Books guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
